Stevens-Johnson syndrome and toxic epidermal necrolysis in Hong Kong

被引:3
作者
Cheung, Christina M. T. [1 ]
Chang, Mimi M. [1 ]
Li, Joshua J. X. [2 ]
Chan, Agnes W. S. [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China
关键词
EPIDEMIOLOGY; MULTIFORME; COHORT; DRUGS;
D O I
10.12809/hkmj2210131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) [hereafter, SJS/ TEN] are uncommon but severe mucocutaneous reactions. Although they have been described in many populations worldwide, data from Hong Kong are limited. Here, we explored the epidemiology, disease characteristics, aetiology, morbidity, and mortality of SJS/TEN in Hong Kong. Methods: This retrospective cohort study included all hospitalised patients who had been diagnosed with SJS/TEN in Prince of Wales Hospital from 1 January 2004 to 31 December 2020. Results: There were 125 cases of SJS/TEN during the 17 -year study period. The annual incidence was 5.07 cases per million. The mean age at onset was 51.4 years. The mean maximal body surface area of epidermal detachment was 23%. Overall, patients in 32% of cases required burns unit or intensive care unit admission. Half of the cases involved concomitant sepsis, and 23.2% of cases resulted in multiorgan failure or disseminated intravascular coagulation. The mean length of stay was 23.9 days. The cause of SJS/TEN was attributed to a drug in 91.9% of cases, including 84.2% that involved anticonvulsants, allopurinol, antibiotics, or analgesics. In most cases, patients received treatment comprising either best supportive care alone (35.2%) or combined with intravenous immunoglobulin (43.2%). The inhospital mortality rate was 21.6%. Major causes of death were multiorgan failure and/or fulminant sepsis (81.5%). Conclusion: This study showed that SJS/TEN are uncommon in Hong Kong but can cause substantial morbidity and mortality. Early recognition, prompt withdrawal of offending agents, and multidisciplinary supportive management are essential for improving clinical outcomes.
引用
收藏
页码:102 / 109
页数:8
相关论文
共 50 条
[21]   Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis [J].
Valeyrie-Allanore, L. ;
Wolkenstein, P. ;
Brochard, L. ;
Ortonne, N. ;
Maitre, B. ;
Revuz, J. ;
Bagot, M. ;
Roujeau, J. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (04) :847-853
[22]   Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis [J].
Yu, Rentao ;
Chen, Shuang ;
Pan, Yun ;
Ma, Chunrong ;
Hu, Li ;
Chen, Aijun ;
Wei, Bin .
JOURNAL OF DERMATOLOGY, 2022, 49 (06) :629-636
[23]   Stevens-Johnson syndrome and toxic epidermal necrolysis: A fresh look at an old foe [J].
Kaimal, Sowmya ;
Lobo, Carol ;
Narayan, Girish ;
Augustine, Mary .
INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (01) :34-40
[24]   French referral center management of Stevens-Johnson syndrome/toxic epidermal necrolysis [J].
Valeyrie-Allanore, Laurence ;
Ingen-Housz-Oro, Saskia ;
Chosidow, Olivier ;
Wolkenstein, Pierre .
DERMATOLOGICA SINICA, 2013, 31 (04) :191-195
[25]   Pregnancies complicated by Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide study [J].
Wasuwanich, Paul ;
Kumari, Jaya ;
So, Joshua M. ;
Egerman, Robert S. ;
Wen, Tony S. ;
Motaparthi, Kiran .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 316 (01)
[26]   Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: What Do We Know? [J].
Tartarone, Alfredo ;
Lerose, Rosa .
THERAPEUTIC DRUG MONITORING, 2010, 32 (06) :669-672
[27]   Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN [J].
Morales, Marlene E. ;
Purdue, Gary F. ;
Verity, Steven M. ;
Arnoldo, Brett D. ;
Blomquist, Preston H. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (04) :505-510
[28]   Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis [J].
Antoon, James W. ;
Goldman, Jennifer L. ;
Lee, Brian ;
Schwartz, Alan .
PEDIATRIC DERMATOLOGY, 2018, 35 (02) :182-187
[29]   Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults [J].
Hsu, Derek Y. ;
Brieva, Joaquin ;
Silverberg, Nanette B. ;
Silverberg, Jonathan I. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (07) :1387-1397
[30]   Ocular manifestation, complications and aetiological factors in Stevens-Johnson syndrome/toxic epidermal necrolysis [J].
Chhipa, Shaukat Ali ;
Masood, Sadia ;
Salarzai, Yasir ;
Khan, Qazi Assad ;
Ahmad, Khabir ;
Sajid, Sara .
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2015, 65 (01) :62-64